Cart
sales@molnova.com
PF-06882961 Tris
CAS No. 2230198-03-3
PF-06882961 Tris( UNII-2HJV78O0SS )
Catalog No. M24014 CAS No. 2230198-03-3
PF-06882961 Tris is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 272 | In Stock |
|
| 10MG | 408 | In Stock |
|
| 25MG | 672 | In Stock |
|
| 50MG | 945 | In Stock |
|
| 100MG | 1278 | In Stock |
|
| 500MG | 2547 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePF-06882961 Tris
-
NoteResearch use only, not for human use.
-
Brief DescriptionPF-06882961 Tris is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist.
-
DescriptionPF-06882961 Tris is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist.
-
In Vitro——
-
In Vivo——
-
SynonymsUNII-2HJV78O0SS
-
PathwayGPCR/G Protein
-
TargetGlucagon Receptor
-
RecptorGLP-1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2230198-03-3
-
Formula Weight676.7
-
Molecular FormulaC35H41FN6O7
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESC1CO[C@@H]1CN2C3=C(C=CC(=C3)C(=O)O)N=C2CN4CCC(CC4)C5=NC(=CC=C5)OCC6=C(C=C(C=C6)C#N)F.C(C(CO)(CO)N)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Méndez M, Matter H, Defossa E, et al. Design, Synthesis, and Pharmacological Evaluation of Potent Positive Allosteric Modulators of the Glucagon-like Peptide-1 Receptor (GLP-1R). J Med Chem. 2020;63(5):2292-2307. doi:10.1021/acs.jmedchem.9b01071
molnova catalog
related products
-
des-His1-[Glu9]-Gluc...
Glucagon receptor antagonist (pA2 = 7.2 for inhibition of glucagon-induced adenylyl cyclase activation in rat liver membranes); displays no agonist activity. Enhances glucose-stimulated pancreatic insulin release in vitro. Blocks added glucagon-induced hyperglycemia in normal rabbits without affecting glycogenolysis in vivo. Also blocks endogenous glucagon-induced hyperglycemia in streptozocin diabetic rats.
-
GLP-1R modulator C16
GLP-1R modulator C16 is a variable modulator that significantly increases the binding affinity of GLP-4.
-
GLP-1R agonist 3
GLP-1R agonist 3 is a potent imidazole derivative and GLP-1R agonist with demonstrated research potential in diabetes. [Thickened]
